ESRP2 and hepatocellular carcinoma: Indeed, ESRP2, SRPK1 and RBM3 have a crucial role in maintaining the appropriate splicing process, and their dysregulation has been described and associated with worse clinical characteristics in tumour pathologies, including HCC.27, 28, 29